Polymorphism of CD14 Gene Is Associated with Adverse Outcome among Patients Suffering from Cardiovascular Disease

<div>Kaplan-Meier plot for the incidence of the (a) combined endpoint (stroke/TIA, myocardial infarction, cardiovascular death, and death from stroke) and (b) cardiovascular death within a 3-year follow-up period according genotype distribution of CD14 SNP rs2569190. Statistical comparison was made by the log-rank test.</div>

Mediators of Inflammation

fig1

Figure 1

Figure 1: Polymorphism of CD14 Gene Is Associated with Adverse Outcome among Patients Suffering from Cardiovascular Disease 